Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Chelsea Therapeutics
Chelsea Therapeutics
FDA grants priority review to Chelsea's hypotension drug
Reuters
Thu, 11/17/11 - 09:01 am
FDA
Chelsea Therapeutics
hypotension
Northera
Chelsea Therapeutics asks FDA to approve Northera
Yahoo/AP
Wed, 09/28/11 - 12:34 pm
FDA
Northera
Chelsea Therapeutics
Parkinson's Disease
5 Cheap Biotech Stocks That May Rebound Ahead of the Market
Seeking Alpha
Fri, 08/12/11 - 12:43 pm
BioSante
Chelsea Therapeutics
Dendreon
Keryx
Opexa
Chelsea Therapeutics: Likely to Double on Safe, Proven Asset
Seeking Alpha
Sat, 07/30/11 - 09:55 am
Chelsea Therapeutics
Droxidopa
CH-4051
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
7 Rallying Biotech Stocks With Conservative Accounting Practices
Seeking Alpha
Fri, 07/1/11 - 09:56 am
Acorda Therapeutics
Incyte
Chelsea Therapeutics
Regeneron
Spectrum Pharmaceuticals
Jazz Pharmaceuticals
Neurocrine
5 Dirt Cheap Biotech Stocks Poised to Triple
Seeking Alpha
Tue, 06/28/11 - 08:53 am
Adventrx
Chelsea Therapeutics
Keryx
Palatin
Rexahn
10 Undervalued Biotech Stocks With Insider Buying
Seeking Alpha
Thu, 06/23/11 - 09:01 am
Chelsea Therapeutics
Corcept Therapeutics
Complete Genomics
Indenix
EXACT Sciences
QLT
MannKind
Theravance
Regeneron
Ziopharm
Biotech Clinical Trials Update: CRIS, ALKS, CHTP
Seeking Alpha
Wed, 06/22/11 - 08:14 am
clinical trials
ALKS 5461
depression
Alkermes
Northera
Chelsea Therapeutics
Multimeric-001
flu vaccine
Chelsea Therapeutics soars on price target upgrade
Marketwatch
Fri, 06/10/11 - 10:35 am
Chelsea Therapeutics
Chelsea Therapeutics International to ask for FDA approval of Northera in the 3rd-quarter
Yahoo/AP
Mon, 04/18/11 - 04:55 pm
Chelsea Therapeutics
FDA
Northera
neurogenic orthostatic hypotension
Low-Priced Biotech Stocks With Insider Buying
Seeking Alpha
Sat, 03/19/11 - 10:06 am
Ligand
Dyax
Bioclinica
Synta Pharmaceuticals
Threshold Pharmaceuticals
Chelsea Therapeutics
Alimera
Cerus
Chelsea Therapeutics has wider 4Q loss on R&D cost
Yahoo/AP
Thu, 03/3/11 - 08:48 am
Chelsea Therapeutics
earnings
Ready for the Biotech Century: Where's the Smart Money Going?
Motley Fool
Tue, 02/8/11 - 04:54 pm
biotech
Codexis
Chelsea Therapeutics
EXACT Sciences
Ziopharm
Chelsea Therapeutics Shares Fly on Hypotension Drug Trials Promise
Seeking Alpha
Tue, 09/21/10 - 12:02 pm
hypotension
Chelsea Therapeutics
Northera
Chelsea rallies on data; drug-sector indexes rise
Marketwatch
Mon, 09/20/10 - 12:37 pm
Chelsea Therapeutics
drug stocks
Northera
Small Cap Biotech Stocks: 7 Picks, 1 Big Concern
Seeking Alpha
Sun, 09/12/10 - 11:20 am
Chelsea Therapeutics
Clinical Data
Savient
DUSA pharmaceuticals
Neurologix
Lpath
Small-Cap Biotech Spikes 50% On P&G Deal
Yahoo/IndieResearch
Wed, 08/25/10 - 12:26 pm
P&G
Somaxon
Amarin
Repros Therapeutics
Chelsea Therapeutics
Amicus Therapeutics
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Chelsea Therapeutics says it will submit new rheumatoid arthritis drug data to FDA in July
Yahoo/AP
Tue, 06/29/10 - 09:51 am
Chelsea Therapeutics
rheumatoid arthritis
FDA
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »